Arcutis Biotherapeutics, Inc. ARQT Business Segments — Total Operating Expenses

Similar metrics at other companies

INDVReportable Segment — Operating Expenses

$139M-10.9%

GBTGReportable Segment — Operating Expenses

$691M+44.0%

ANDGReportable Segment — Operating Expenses

$216.67M+39.4%

ELFReportable Segment — Operating Expenses

$376.79M+95.5%

PCVXReportable Segment — Operating Expenses

$345.85M+91.3%

CONReportable Segment — Total Costs & Expenses

$448.87M+12.8%

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses?

Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — total operating expenses of $114.49M in Q1 2026.

How has Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses changed year-over-year?

Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses increased by 26.7% year-over-year, from $90.38M to $114.49M.

What is the long-term trend for Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses?

Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s business segments — total operating expenses has grown at a 8.3% compound annual growth rate (CAGR), from $305.31M to $388.3M.

What does business segments — total operating expenses mean?

The aggregate of all operating costs, including cost of sales, R&D, SG&A, and other segment-specific expenses. This metric provides a comprehensive view of the total capital required to maintain the segment's ongoing business operations.